Role of ionotropic glutamate receptors in delay and probability discounting in the rat

被引:0
作者
Justin R. Yates
Seth R. Batten
Michael T. Bardo
Joshua S. Beckmann
机构
[1] Northern Kentucky University,Department of Psychological Science
[2] University of Kentucky,Department of Psychology
[3] University of Kentucky,Department of Anatomy and Neurobiology
[4] University of Kentucky,Center for Drug Abuse Research Translation
来源
Psychopharmacology | 2015年 / 232卷
关键词
Discounting; Delayed reinforcement; Probabilistic reinforcement; NMDA receptor; AMPA receptor; Rat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1187 / 1196
页数:9
相关论文
共 185 条
[1]  
Ainslie G(1975)Specious reward: a behavioral theory of impulsiveness and impulse control Psychol Bull 82 463-496
[2]  
Almasi-Nasrabadi M(2012)Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice Behav Brain Res 231 138-145
[3]  
Javadi-Paydar M(1991)MK-801 inhibition of nicotinic acetylcholine receptor channels Synapse 7 207-215
[4]  
Mahdavian S(2012)Delay and probability discounting in pathological gamblers with and without a history of substance use problems Psychopharmacology (Berl) 219 491-499
[5]  
Babaei R(2004)Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior Alcohol Clin Exp Res 28 558-565
[6]  
Sharifian M(1999)Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers Psychopharmacology (Berl) 146 447-454
[7]  
Norouzi A(1997)The non-competitive NMDA antagonist MK-801 increases food intake in rats Pharmacol Biochem Behav 56 145-149
[8]  
Dehpour AR(2003)Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals Exp Clin Psychopharmacol 11 18-25
[9]  
Amador M(2013)The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats Psychopharmacology (Berl) 226 127-138
[10]  
Dani JA(1997)Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents—preclinical studies Neurosci Biobehav Rev 21 455-468